𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

✍ Scribed by Robert L. Grubb III; Paul F. Pinsky; Robert T. Greenlee; Grant Izmirlian; Anthony B. Miller; Thomas P. Hickey; Thomas L. Riley; Jerome E. Mabie; David L. Levin; David Chia; Barnett S. Kramer; Douglas J. Reding; Timothy R. Church; Lance A. Yokochi; Paul A. Kvale; Joel L. Weissfeld; Donald A. Urban; Saundra S. Buys; Edward P. Gelmann; Lawrence R. Ragard; E. David Crawford; Philip C. Prorok; John K. Gohagan; Christine D. Berg; Gerald L. Andriole


Book ID
109055509
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
186 KB
Volume
102
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Large-scale randomized prostate cancer s
✍ Harry J. de Koning; Anssi Auvinen; Antonio Berenguer Sanchez; Fernando Calais da πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 79 KB πŸ‘ 2 views

## Abstract Two large‐scale randomized screening trials, the Prostate, Lung, Colorectal and Ovary (PLCO) cancer trial in the USA and the European Randomized Screening for Prostate Cancer (ERSPC) trial in Europe are currently under way, aimed at assessing whether screening reduces prostate cancer mo

The prostate, lung, colorectal, and ovar
✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 481 KB πŸ‘ 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female